Heterozygous STAT1 gain of function (GOF) variants in patients with chronic mucocutaneous candidiasis (CMC) are associated with PD-L1 overexpression and diminished TH17 activity. This evidence concerns the gene CD274 and chronic mucocutaneous candidiasis.